CombiGene AB engages in the development of new treatment for neurological diseases. It focuses on the research of therapy for patients with epilepsy. The company was founded by Lars Thunberg, Merab Kokaia and David Woldbye in 1990 and is headquartered in Lidingoe, Sweden.